Gang‐Ming Zou

1.1k total citations
27 papers, 820 citations indexed

About

Gang‐Ming Zou is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Gang‐Ming Zou has authored 27 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Surgery. Recurrent topics in Gang‐Ming Zou's work include Pluripotent Stem Cells Research (5 papers), RNA Interference and Gene Delivery (5 papers) and MicroRNA in disease regulation (5 papers). Gang‐Ming Zou is often cited by papers focused on Pluripotent Stem Cells Research (5 papers), RNA Interference and Gene Delivery (5 papers) and MicroRNA in disease regulation (5 papers). Gang‐Ming Zou collaborates with scholars based in China, United States and France. Gang‐Ming Zou's co-authors include Wei Wu, Jianjun Chen, Miao Sun, Ru‐Lin Huang, Jun Tu, Wen‐Yang Hu, Guangwang Liu, Qingfeng Li, Yasuaki Kabe and Anirban Maitra and has published in prestigious journals such as PLoS ONE, International Journal of Cancer and Journal of Cellular Physiology.

In The Last Decade

Gang‐Ming Zou

27 papers receiving 805 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gang‐Ming Zou China 15 537 276 140 115 88 27 820
Jason Whitt United States 11 478 0.9× 268 1.0× 160 1.1× 90 0.8× 64 0.7× 26 807
Masashi Shin Japan 17 580 1.1× 206 0.7× 188 1.3× 83 0.7× 51 0.6× 27 823
Jang‐Seong Kim South Korea 14 337 0.6× 179 0.6× 132 0.9× 92 0.8× 119 1.4× 27 662
Sergey Tkachuk Germany 16 260 0.5× 218 0.8× 93 0.7× 143 1.2× 84 1.0× 23 647
Donglin Luo China 17 599 1.1× 410 1.5× 168 1.2× 73 0.6× 128 1.5× 38 965
Zheng Xu China 20 588 1.1× 301 1.1× 126 0.9× 63 0.5× 142 1.6× 41 872
Wenchang Lv China 16 546 1.0× 353 1.3× 139 1.0× 113 1.0× 79 0.9× 34 869
Ida Katrine Lund Denmark 18 335 0.6× 356 1.3× 264 1.9× 132 1.1× 83 0.9× 43 839
Céline Deroyer Belgium 11 387 0.7× 229 0.8× 78 0.6× 69 0.6× 76 0.9× 23 890
Guochun Zhu United States 18 650 1.2× 195 0.7× 252 1.8× 114 1.0× 40 0.5× 25 882

Countries citing papers authored by Gang‐Ming Zou

Since Specialization
Citations

This map shows the geographic impact of Gang‐Ming Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gang‐Ming Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gang‐Ming Zou more than expected).

Fields of papers citing papers by Gang‐Ming Zou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gang‐Ming Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gang‐Ming Zou. The network helps show where Gang‐Ming Zou may publish in the future.

Co-authorship network of co-authors of Gang‐Ming Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Gang‐Ming Zou. A scholar is included among the top collaborators of Gang‐Ming Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gang‐Ming Zou. Gang‐Ming Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhong, Shan, Chengshui Chen, Yang Li, et al.. (2023). Identification of circRNA-associated ceRNA networks in peripheral blood mononuclear cells as potential biomarkers for chronic obstructive pulmonary disease. Bioscience Reports. 43(10). 1 indexed citations
2.
Zhang, Junli, et al.. (2022). Anticancer effects and mechanisms of astragaloside‑IV (Review). Oncology Reports. 49(1). 26 indexed citations
3.
Jiang, Yiping, Lijuan Zhang, Qiuyu Li, et al.. (2021). The abnormal fractional amplitude of low-frequency fluctuation changes in patients with diabetic optic neuropathy: a steady-state fMRI study. Journal of Integrative Neuroscience. 20(4). 885–893. 1 indexed citations
4.
Zou, Gang‐Ming. (2017). RNAi Technique in Stem Cell Research: Current Status and Future Perspectives. Methods in molecular biology. 1622. 3–14. 3 indexed citations
5.
Zou, Gang‐Ming, et al.. (2017). RNAi Knockdown of Ape1 Gene in the Differentiation of Mouse Embryonic Stem Cells. Methods in molecular biology. 1622. 131–138. 2 indexed citations
6.
Jiang, Shaojie, Lina Zhu, Haimei Tang, et al.. (2015). Ape1 regulates WNT/β-catenin signaling through its redox functional domain in pancreatic cancer cells. International Journal of Oncology. 47(2). 610–620. 20 indexed citations
7.
Chen, Zhihua, et al.. (2014). Characterization of Interstitial Cajal Progenitors Cells and Their Changes in Hirschsprung’s Disease. PLoS ONE. 9(1). e86100–e86100. 13 indexed citations
8.
Zhu, Lina, et al.. (2014). Aberrant expression of redox protein Ape1 in colon cancer stem cells. Oncology Letters. 7(4). 1078–1082. 38 indexed citations
9.
Huang, Ru‐Lin, et al.. (2014). Exaggerated inflammatory environment decreases BMP-2/ACS-induced ectopic bone mass in a rat model: implications for clinical use of BMP-2. Osteoarthritis and Cartilage. 22(8). 1186–1196. 34 indexed citations
10.
11.
Liu, Changlong, et al.. (2012). LIGHT regulates the adipogenic differentiation of mesenchymal stem cells. Journal of Cellular Biochemistry. 114(2). 346–353. 8 indexed citations
12.
Zou, Gang‐Ming. (2010). RNAi in Stem Cells: Current Status and Future Perspectives. Methods in molecular biology. 650. 3–14. 4 indexed citations
13.
Zou, Gang‐Ming, Collins Karikari, Yasuaki Kabe, et al.. (2008). The Ape‐1/Ref‐1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: Therapeutic implications in tumor angiogenesis. Journal of Cellular Physiology. 219(1). 209–218. 61 indexed citations
14.
Zou, Gang‐Ming. (2007). Cancer stem cells in leukemia, recent advances. Journal of Cellular Physiology. 213(2). 440–444. 33 indexed citations
15.
Wu, Wei, Miao Sun, Gang‐Ming Zou, & Jianjun Chen. (2006). MicroRNA and cancer: Current status and prospective. International Journal of Cancer. 120(5). 953–960. 211 indexed citations
16.
Zou, Gang‐Ming & Wen‐Yang Hu. (2005). LIGHT regulates CD86 expression on dendritic cells through NF‐κB, but not JNK/AP‐1 signal transduction pathway. Journal of Cellular Physiology. 205(3). 437–443. 35 indexed citations
17.
Zou, Gang‐Ming & Mervin C. Yöder. (2005). Application of RNA interference to study stem cell function: current status and future perspectives. Biology of the Cell. 97(3). 211–219. 17 indexed citations
18.
Zou, Gang‐Ming, Wei Wu, Jianjun Chen, & Janet D. Rowley. (2003). Duplexes of 21‐nucleotide RNAs mediate RNA interference in differentiated mouse ES cells. Biology of the Cell. 95(6). 365–371. 34 indexed citations
19.
Zou, Gang‐Ming, et al.. (2000). IFN‐γ induces apoptosis in mouse embryonic stem cells, a putative mechanism of its embryotoxicity. Development Growth & Differentiation. 42(3). 257–264. 17 indexed citations
20.
Zou, Gang‐Ming, et al.. (2000). Fas‐Mediated Apoptosis of Mouse Embryo Stem Cells: Its Role During Embryonic Development. American Journal of Reproductive Immunology. 43(4). 240–248. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026